Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in the United States is expected to begin later this year.
If you enjoy this content, please share it with a colleague
- Read more about First Drug-Eluting Balloon Brought Before the FDA
- Log in or register to post comments
